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PURPOSE. Recently, gene-targeted strains of mice with null mu-
tations for specific proteoglycans (PGs) have been used for
investigations of the functional role of these molecules. In the
present study, the corneal stroma of the mouse was examined
to provide some baseline PG morphologies in this species.
METHODS. Monoclonal antibodies to specific glycosaminogly-
can (GAG) chain sulfation patterns were used to characterize
PG composition in corneal extracts by SDS-PAGE and Western
blot analysis and to identify their tissue distribution by immu-
nofluorescence microscopy. PGs were also visualized by trans-
mission electron microscopy after contrast enhancement with
cationic dye fixation.
RESULTS. Western blot analysis of pooled corneal extracts and
immunofluorescence of tissue sections identified 4-sulfated,
but not 6-sulfated, chondroitin sulfate/dermatan sulfate (CS/
DS). Keratan sulfate (KS) was present only as a low-sulfated
moiety. Electron microscopic histochemistry disclosed a com-
plex array of corneal PGs present as (1) fine filaments radiating
from collagen fibrils, and (2) elongate, straplike structures,
running either along the fibril axis or weaving across the
primary fibril orientation. These large structures were digested
by chondroitinase ABC, but not by keratanase.
CONCLUSIONS. KS in the mouse is predominantly undersulfated
and generates an immunostaining pattern that differs from that
observed in corneas of other mammalian species thus far in-
vestigated. The mouse cornea resembles other mammalian
corneas in the presence of filamentous arrays of small, collag-
en-associated stromal PGs visualized by cationic dye staining.
However, large dye-positive structures with a CS/DS compo-
nent are also present and appear to be unique to the cornea of
this species. (Invest Ophthalmol Vis Sci. 2005;46:1973–1978)
DOI:10.1167/iovs.04-1309
Proteoglycans (PGs) are key components of the cornealstroma where, as in other connective tissues, they contrib-
ute to the interfibrillar compartment of the matrix. The internal
fine structure of the corneal stroma has functional significance,
with the uniform diameter and characteristic spatial organiza-
tion of collagen fibrils believed to be essential for tissue trans-
parency.1–4 Much evidence points to a role for PGs in the
regulation of tissue architecture through interactions with
fibrillar collagen and control of fibril size5–7 and arrange-
ment.8–10
The small leucine-rich PGs in cornea are macromolecules
consisting of a protein backbone to which variable numbers of
repeat disaccharide—that is, glycosaminoglycan (GAG)—side
chains are covalently attached. The main corneal GAGs are
chondroitin sulfate/dermatan sulfate (CS/DS) and keratan sul-
fate (KS), the former linked to protein as decorin and bigly-
can,11,12 and the latter contributing to the three corneal KS
PGs, lumican,13 keratocan,14 and mimecan.15 Advances in mo-
lecular genetics in recent years have allowed the generation of
strains of mice with null mutations in selected PGs, and these
offer many advantages for rapid progress in our understanding
of the roles of PGs in the cornea.16–21 The advent of mouse
strains with multiple genetic alterations will further enhance
such work. However, the normal mouse cornea is thought to
differ from the corneas of other, larger mammals, particularly
in relation to its KS content.22–24 To underpin investigations of
PG structure–function relationships using mice with experi-
mental gene knockouts, a more comprehensive appreciation of
PGs and GAGs in the corneal stroma of the normal mouse is
needed. In this report we highlight some species-specific char-
acteristics of the normal mouse corneal stroma from electron
microscopy and immunofluorescence microscopy using mono-
clonal antibodies specific for different sulfation patterns on
CS/DS- and KS-GAG chains.
METHODS
Mature 12- to 15-week-old BALBc and C57/B6 strain mice were ob-
tained from breeding colonies maintained at the School of Biosciences,
Cardiff University. At all times animals were treated in accordance with
the ARVO Statement for the Use of Animals in Ophthalmic and Vision
Research and in compliance with local ethical regulations. Eyes were
removed within 5 minutes postmortem after halothane anesthesia and
cervical dislocation.
Corneal Extraction and Immunoblotting
One hundred corneas were extracted in 4 M guanidine hydrochloride
for 12 hours at 4°C in the presence of protease inhibitors (0.05 M
sodium acetate, 0.01 M disodium EDTA, 0.1 M 6-amino hexanoic acid,
0.005 M benzamidine HCl, and 0.5 mM PMSF [pH 5.8–6.8]). Superna-
tants were collected, and the tissue was subjected to repeat extraction
for a further 12 hours at 4°C. Pooled extracts were dialyzed into 6 M
urea in 0.1 M Tris-HCl, 0.1% CHAPS (3-([3-cholamidopropyl]dimethyl-
ammonio-2-hydroxy-1-propanesulfonate). The crude PG extract was
applied to a diethylaminoethyl (DEAE) Sepharose fast flow anion ex-
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change chromatography resin (Amersham Pharmacia Biotech, Piscat-
away, NJ). Bound PGs were eluted with 1.5 M NaCl, then dialyzed into
double-distilled water (Milli-Q; Millipore, Bedford, MA). Dimethylmeth-
ylene blue analysis revealed 60 g GAG in the preparation. The sample
was freeze dried and reconstituted in 60 L 0.1 M Tris acetate (pH 6.8).
A portion of the sample (30 L) was digested with 0.01 U keratanase
(EC 3.2.1.103; MP Biomedicals [formerly ICN Biomedicals], Irvine,
CA), and 0.01 U chondroitinase ABC (EC 4.2.2.4; Sigma-Aldrich, Poole,
UK) per milligram GAG.
Digested and undigested samples were mixed with an equal vol-
ume of 2 SDS buffer (0.125 M Tris-HCl, 4% SDS, 20% glycerol, and
0.01% bromophenol) and 10% -mercaptoethanol. The samples were
reduced by boiling for 5 minutes, and subsequently 3 g of GAG was
loaded onto 4% to 20% Tris glycine gradient gels (Invitrogen, Renfrew,
UK) for Western blot analysis using the monoclonal antibodies 5D4,
1B4, 4D1, 1B5, 2B6, and 3B3. These antibodies are well character-
ized25–28 and are specific for KS or CS/DS-GAGs on PGs. They recog-
nize discrete epitopes defined by sulfation patterns on the disaccharide
chains, some of which require exposure by partial predigestion with
purified enzymes (summarized in Table 1). Chondroitinase and kera-
tanase digestion were normally used in tandem to generate the immu-
noepitope and facilitate antibody penetration.
Antibody 2B6 can also be used to investigate the presence of both
DS- and CS-GAG chains on mouse corneal CS PGs by differential
digestion with chondroitinase ABC and AC II enzymes. This is possible
because chondroitinase ABC digestion generates 2B6-reactive neo-
epitope from both CS- and DS-GAG chains, whereas chondroitinase AC
II does not digest DS and thus only generates the neoepitope C-4-S
“stub” from CS chains. Chondroitinase AC II (AC II Arthro 4.2.2.5;
Seikagaku Corp., Tokyo, Japan), digestion of corneal extracts was as
described earlier for chondroitinase ABC.
Immunohistochemistry
Mouse eye lenses were removed through an anterior scleral incision,
and the eyes were placed in optimal cutting temperature (OCT) com-
pound and plunge frozen in liquid nitrogen-cooled isopentane. After
storage at 20°C, serial 8-m-thick sagittal sections were prepared on
a cryostat and collected on glass slides. In addition, some sections were
prepared for use as positive control specimens for antibody reactivity
from full-thickness slices of bovine articular cartilage, dissected from
the metacarpophalangeal joints of 18-month-old steers obtained from a
local abattoir.
Sections were probed with the panel of monoclonal antibodies
described in Table 1 and detected with FITC-conjugated goat anti-
mouse Fab-FITC (Dako, High Wycombe, UK). Background signal, ow-
ing to labeling of endogenous mouse IgG by anti-mouse secondary
antibody was avoided, by using the method of Hierck et al.29 Briefly,
antibody supernatants and ascites fluids were diluted 1:10 and 1:500,
respectively, with PBS and the secondary FITC-conjugated goat anti-
mouse antibody was diluted 1:50 in this solution. Primary and second-
ary antibodies were complexed overnight at 4°C. Heat-inactivated
normal mouse serum was added to 0.1% concentration and mixed at
room temperature for 30 minutes to absorb uncomplexed secondary
antibody. Thawed, unfixed sections, with or without predigestion for
2 to 3 hours at 37°C with 0.4 U/mL chondroitinase ABC or chondroiti-
nase AC II (0.4 U/mL), or keratanase (0.04 U/mL), were immersed in a
blocking buffer for 30 minutes at room temperature (150 mM NaCl, 10
mM Tris-HCl, 5 mM EDTA, and 0.05% [vol/vol] Tween-20 [pH 8.0]).
After sections were washed in PBS, they were incubated in the anti-
body mixture for a minimum of 4 hours at room temperature in a
humid chamber. Nuclei in sections were counterstained with Hoechst
33258 before mounting in antifade medium.
Electron Microscopy
For visualization of PGs, corneas were isolated and fixed for approxi-
mately 18 hours in 2.5% glutaraldehyde in 25 mM sodium acetate
buffer (pH 5.7), with 0.1 M magnesium chloride and 0.05% cupro-
meronic blue.22–24 After the specimens were washed in buffer, con-
trast enhancement of stained PG-dye complexes was performed by
15-minute washes of fixed tissue in aqueous, then 50% ethanolic 0.5%
sodium tungstate solutions. Specimens were dehydrated in an ascend-
ing ethanol series and, through propylene oxide, embedded in Araldite
resin. To investigate the PG composition of stained complexes, some
samples were first exposed to predigestion with GAG-degrading en-
zymes to remove specific PG components of the cupromeronic blue
staining pattern. To facilitate enzyme penetration, this procedure was
performed on 50-m cryostat sections taken through the center of the
cornea, collected on glass slides, and digested for 4 hours at 37°C with
either keratanase (1 U/mL in Tris-acetate buffer [pH 8.0]) to degrade
KS, or chondroitinase ABC (2.5 U/mL in Tris-acetate buffer [pH 7.4]),
to degrade 0-, 4- and 6-sulfated CS and DS. Corneal sections were then
fixed and stained as described earlier and detached from slides for resin
embedding. Ultrathin sections (90 nm thick) of central cornea were
cut with a diamond knife, collected on copper grids, and stained with
1% PTA and 0.5% UA at 40°C, before examination in a transmission
electron microscope (EM208; Philips, Eindhoven, The Netherlands).
RESULTS
Western Blot Analysis of Mouse PG Extracts
Mouse corneal extracts were analyzed with a range of antibod-
ies raised against native epitopes on KS PGs that were specific
for different linear sulfation motifs on the molecule. Monoclo-
nal antibody 5D4, which is reactive with highly sulfated motifs,
failed to demonstrate discrete bands, although small amounts
of highly sulfated material were present, as evident by a reduc-
tion in positive immunostaining on digestion with keratanase
(Fig. 1A, lanes 1, 2). In contrast, antibodies 1B4 and 4D1,
which both react with lesser-sulfated KS motifs were strongly
positive—again, over a broad spread of molecular mass,70 to
TABLE 1. Antibodies Used in Immunoblot Analysis and Immunohistochemistry
Antibody Epitope Tissue Pretreatment Required References
5D4 Linear pentasulfated sequences of N-acetyl
lactosamine disaccharides of KS PGs in which
both the GalNAC and Gal are sulfated
None 25–28
1B4 Lesser sulfated sequences of N-acetyl lactosamine
disaccharides of KS PGs
None 26–28
4D1 Similar to 1B4 None —
1B5 0-Sulfated unsaturated disaccharide “stubs” (C-0-S)
on CS/DS PGs
Chondroitinase ABC to generate neoepitope “stub” 26
2B6 4-Sulfated unsaturated disaccharide “stubs” (C-4-S)
on CS/DS PGs
Chondroitinase ABC to generate neoepitope “stub” 26
3B3 6-Sulfated unsaturated disaccharide “stubs” (C-6-S)
on CS/DS PGs
Chondroitinase ABC to generate neoepitope “stub” 26
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250 kDa (Fig 1A, lanes 4, 6). This immunopositive staining
was removed by digestion with keratanase (Fig. 1A, lanes 3, 5).
Monoclonal antibodies 1B5, 2B6, and 3B3 showed the
predominant CS/DS PG to contain the 4-sulfated stub isomer
present on a CS PG core protein (Fig. 1B, lane 4). 1B5 gave
only weak staining, whereas the nitrocellulose was un-
stained with 3B3, indicating trace and undetectable amounts
of 0- and 6-sulfated CS, respectively (Fig. 1B, lanes 2, 7). A
strong immunostaining band was observed at approximately
37 kDa with 2B6 antibody after chondroitinase ABC diges-
tion, representing neoepitope potentially generated from
4-sulfated CS and/or DS chains (Fig. 1B, lane 4). In contrast,
chondroitinase AC II digestion produced a fainter band at 37
kDa, plus a spread of immunoreactivity across the nitrocel-
lulose at higher molecular weight. This probably repre-
sented partially digested CS/DS PGs with either both CS and
DS or CS/DS copolymers substituted on their core proteins
(Fig. 1B, lane 5).
Mouse corneal PG extracts isolated under reducing condi-
tions and run on Tris-glycine gradient gels consistently revealed
contamination at 25 and 50 kDa by endogenous mouse IgG
light and heavy chains, respectively (Fig. 1). This reflected a
relatively high concentration of endogenous immunoglobulin,
for a nonvascularized tissue such as the corneal stroma. The
presence of IgG necessitated modifications to immunohisto-
chemistry methodology, using anti-mouse secondary antibod-
ies, as will be detailed later.
Stromal Localization of Specific PGs by
Immunohistochemistry
Immunolabeling of mouse corneal PGs was successfully
achieved using monoclonal antibodies and anti-mouse second-
ary antibodies when we used a one-step incubation of sections
in a mixture of primary–secondary antibody complexes, sup-
plemented with normal mouse serum.29 Both conventional
two-step staining and incubation with complexes, or second-
ary antibody alone in the absence of normal serum, generated
overwhelming levels of background fluorescence, presumably
owing to binding of the secondary antibody to endogenous
mouse corneal IgG (Fig. 2A). Control sections exposed to
secondary antibody plus serum, but with primary antibody
omitted, displayed low levels of background fluorescence
(Fig. 2B).
In general, immunohistochemistry confirmed the results of
Western blot analysis. Thus, antibody 5D4 against minimally
pentasulfated disaccharides on KS consistently gave negative
results (Fig. 2C, 2D), whereas relatively strong fluorescence
was observed with antibody 1B4, specific for lower-sulfated
linear sulfation epitopes (Fig. 2F). This 1B4 signal was eradi-
cated by keratanase pretreatment, thus verifying KS staining
(Fig. 2G). A positive control for the 5D4 antibody was demon-
strated by immunofluorescence staining of bovine articular
cartilage using the same dilutions of primary and secondary
antibody (Fig. 2E).
In line with the results from Western blot analysis, only low
levels of staining were obtained with antibody 1B5, which
recognized chondroitinase-generated 0-sulfated CS stubs on
CS/DS PGs, whereas results with 3B3, which recognizes the
6-sulfated stub isomer, were consistently negative (results not
shown). However, a strong positive immunoreactivity was
detected throughout the stroma to monoclonal antibody 2B6,
which recognized the 4-sulfated isomer stubs (Figs. 2I, 2J). As
predicted, this immunostaining was dependent on chondroiti-
nase digestion to expose the neoepitope for antibody 2B6
(Figs. 2I, 2L). Levels of immunostaining with 2B6 antibody after
chondroitinase AC II treatment were similar to those obtained
after chondroitinase ABC, indicating that CS was the predom-
inant GAG present (Figs. 2J, 2M). Similar immunopositive stain-
ing patterns were observed with antibody 2B6 in control sec-
tions of articular cartilage after chondroitinase ABC or AC II
pretreatment (Figs. 2K, 2N).
Unique Ultrastructure of Mouse Corneal PGs
Visualized by Cationic Dye Staining
Cupromeronic blue staining patterns revealed two populations
of mouse corneal PGs (Fig. 3). A large number of fine filaments
could be seen radiating from the collagen fibrils in the longi-
tudinal section, where they sometimes exhibited regular asso-
ciations with the D-periodic bands of the positively stained
fibrils. In addition, much larger dye-positive structures with
diameters up to 20 nm and maximum measurable length of
approximately 600 nm were present. These conspicuous struc-
tures appeared variously as sinuously curved or linear ele-
ments, running at various angles with respect to the fibril axis
within the lamellae and with threadlike extensions arising at
intervals along them, sometimes making contact with adjacent
collagen fibrils.
The cupromeronic-blue–positive structures responded
differently to incubation with GAG-degrading enzymes (Fig.
FIGURE 1. (A) Western blot analysis of corneal extract exposed to
monoclonal antibodies specific for KS PG. Lanes 1, 3, 5: extract treated
with chondroitinase and keratanase; lanes 2, 4, 6: untreated. The small
amount of 5D4 reactivity indicate low levels of minimally pentasulfated
disaccharides present on KS-GAG-substituted PGs. 1B4 and 4D1
showed strong reactivity for lower-sulfated KS substitution on mouse
corneal KS PGs. (B) Western blot analysis of corneal extract exposed
to monoclonal antibodies specific for chondroitinase-generated neo-
epitope stubs on chondroitin 0- (1B5), 4- (2B6) and 6-sulfate (3B3).
Lanes 1, 3, 6: sample not treated with enzymes; lanes 2, 4, 7: sample
digested with keratanase and chondroitinase ABC enzyme; and lane 5:
sample digested with keratanase and chondroitinase AC. 4-Sulfated CS
and DS contributed to a strong staining band (lane 4), which spread up
the gel after chondroitinase AC digestion (lane 5) of CS, but not DS,
chains. Some 0-sulfated CS stubs were present (lane 2), but CS-6-sulfate
stubs were not detected on these corneal CS/DS PGs (lane 7). Bands
representing IgG heavy and light chains are indicated.
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4). Chondroitinase ABC pretreatment removed the large
filaments (Figs. 4G–I), although they were resistant to diges-
tion by keratanase I (Figs. 4D–F). Numerous fine filaments
were resistant to keratanase and were often located along
the collagen fibrils. Chondroitinase ABC enzyme treat-
ment left only poorly contrasted, dye-positive structures,
which appeared smaller than those remaining after kerata-
nase digestion and could sometimes be assigned to “a/c”
collagen bands. No clear differences were evident between
the anterior, mid, and posterior zones of the mouse corneal
stroma.
DISCUSSION
Investigations by electron microscopy have shown close and
specific interactions between PGs and collagen fibrils in a
range of connective tissues including tendon,30–32 bone,33
intervertebral disc,34 articular cartilage,35 sclera,36,37 and cor-
nea.38–40 In the cornea, these regular and characteristic inter-
actions support the hypothesis that PGs fulfill an essential role
in the maintenance of matrix integrity and function with cru-
cial importance for regulating collagen fibril diameter and tis-
sue transparency. The introduction of gene targeted mutant
mice with deficiencies in PGs currently offers great potential in
furthering our understanding of the functions of these impor-
FIGURE 2. Immunofluorescence detection of PGs in mouse cornea
with monoclonal antibodies against specific sulfated KS and CS/DS-
GAGs. Positive staining was shown by FITC (green), and Hoechst
33258 dye (red) counterstained the cell nuclei. (A) A high level of
nonspecific fluorescence in mouse cornea in a control section, from
which the primary antibody was omitted, was attributed to staining of
endogenous mouse IgG by anti-mouse secondary antibody in the ab-
sence of normal mouse serum. ep, corneal epithelium; s, corneal
stroma. (B) Background staining was eradicated in a control section
when serum was included and antibody solutions were applied using
the method described by Hierck et al.29 (C, D) Immunolocalization of
mouse corneal KS PGs with antibody 5D4 was negative, indicating that
no highly sulfated KS epitopes were detectable. In contrast, low sul-
fated KS was labeled by antibody 1B4 (F). This staining was removed
by keratanase pretreatment (G). Both 5D4 (E) and 1B4 (H) antibodies
gave positive immunofluorescence in bovine articular cartilage. (I, J)
Immunolocalization of chondroitinase-generated chondroitin 4-sulfate
isomer stubs with antibody 2B6 throughout the corneal stroma with no
clear difference in signal intensity between sections pretreated with
either chondroitinase ABC or chondroitinase AC II. (L,M) Staining was
absent without enzyme predigestion to expose the neoepitope for the
2B6 antibody. (K, N) As with mouse cornea, bovine articular cartilage
showed positive staining with 2B6 after either enzyme pretreatment.
FIGURE 3. Ultrastructure of PGs in mouse cornea after contrast-en-
hanced fixation with cupromeronic blue. PGs appeared as electron
dense filaments, sometimes regularly associated with the collagen
fibrils (short arrows) seen in the longitudinal section, and as large,
elongated structures which ran along and across the fibrils (long
arrows). These large structures appeared circular in a transverse sec-
tion, up to 20 nm in diameter, and with radiating extensions (arrow-
heads). Bar, 250 nm.
FIGURE 4. Effects of enzyme pretreatment on the structure of cupro-
meronic blue-contrasted PGs in anterior, mid, and posterior stroma of
mouse cornea (left, middle, and right columns, respectively). A nor-
mal complement of PGs was present in cornea that was incubated in
buffer without enzyme (A–C). Keratanase treatment (D–E) has little
effect, apart from some slight reduction in collagen-associated fila-
ments. Chondroitinase ABC (G–I) treatment removes large PG struc-
tures leaving variable amounts of collagen-associated filaments. Chon-
droitinase-resistant material (G–I) appeared as small, low-contrast
filaments, presumed to represent KS PGs. Bar, 200 nm.
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tant molecules in the cornea.41,42 Recent work has shown that
a deficiency in lumican leads to abnormally large collagen
fibrils in skin and cornea and to opacification of the cornea,16
whereas mice deficient in mimecan or keratocan also exhibit
larger fibrils and disturbed fibril organization, but without loss
of tissue transparency.19,21
Interpretation of the role of corneal PGs from studies of
genetically altered mouse strains is crucially dependent on an
appreciation of PG composition in the normal animal. Findings
in earlier studies of mouse corneal PGs, in particular KS, are
controversial. This PG was detectable in mouse corneal stroma
by immunolocalization with the monoclonal antibody MZ15,43
yet electron microscopy and biochemical studies showed it to
be absent, or at undetectable levels, compared to rat and rabbit
cornea.44 A subsequent comparative study of corneas in sev-
eral vertebrates found KS was indeed present in mouse cornea,
but suggested that it lacked oversulfated disaccharide motifs.23
In this respect, mouse cornea appears to differ significantly
from corneas in other mammalian species, where the KS PGs
lumican and keratocan carry highly sulfated KS chains. Re-
cently, Ying et al.45 found lumican core protein without KS
chains to be abundant in neonatal mouse cornea by day 10,
with sulfated KS evident after the eyes opened, although the
extent of sulfation was not assessed in this study. Keratan
sulfate chains may also be absent from mimecan in mouse
cornea, in contrast to bovine and human corneas.21
To clarify PG composition and structure in mouse cornea,
we performed an investigation involving a range of antibodies
sensitive to specific variations in sulfation patterns on KS and
CS PGs. Immunoblot analysis of corneal PG extracts demon-
strated a low level of reactivity with antibody 5D4, but rela-
tively strong signal with antibodies 1B4 and 4D1, thus confirm-
ing the absence of extended sequences of disulfated
disaccharides on KS-GAGs in the mouse. These observations
were corroborated by immunolocalization showing lower sul-
fated KS PG distributed evenly throughout the stromal thick-
ness. Chondroitin 4-sulfate was the most readily detectable CS
PG, with 0-sulfated CS also present, but no 6-sulfated CS PG
identified. Previous studies on other connective tissues have
shown a consistent increase in the ratio of 6:4 sulfated CS PG
with age.46,47 No studies of CS 6:4 sulfate ratios with age have
yet been performed on mouse cornea, but corneas examined
in the present study were from young adults and the possibility
that C-6-S may appear in the stroma of aged mice cannot be
excluded. Differential digestion of mouse corneal C-4-S PG
with chondroitinase ABC or AC II demonstrated an underlying
heterogeneity of CS/DS-substituted PGs reflected in altered
staining patterns on immunoblots with antibody 2B6. Accord-
ing to one earlier report, mouse cornea may contain more than
60% of CS/DS PG as DS.23 Our results also indicate the pres-
ence of DS. They further indicate that most CS is 4-sulfated
rather than 0- or 6-sulfated. We contend that CS chains in
mouse cornea may exhibit structural diversity similar to that
recently described in bovine cornea,48 and that core protein
substituted with co-polymeric CS/DS chains, as well as with CS
and DS chains individually, may coexist in the mouse stroma.
The ultrastructural organization of mouse corneal PGs, vi-
sualized with cupromeronic blue, is evidently more complex
than that described previously in other mammalian corneas.
Broadly, two types of dye-PG complexes were identifiable in
the present study: fine collagen-associated filaments and un-
usually large, straplike structures. Dye-positive fine filamentous
PGs are reminiscent of those previously described in other
species. However, the most striking feature of corneas exam-
ined by electron microscopy was the presence of a population
of large, intensely dye-positive complexes found draped along
or wrapped around collagen fibrils in longitudinal section. We
believe that these PGs represent structures unique to the
mouse cornea and although their presence has been illustrated
once previously in the literature,44 they have hitherto been
overlooked as the attention of most researchers has been
focused on the site-specific binding of the small collagen-
associated PGs in this tissue. However, the large PG complexes
constitute an abundant component of the stroma and they may
therefore confer on the mouse cornea some important func-
tional properties. Published studies of corneas from other ro-
dent species44,49 have not revealed PG structures resembling
these in mouse. To date, our attempts to characterize the large
PGs with specific antibodies by immunoelectron microscopy
have been unsuccessful. Nevertheless, we show in this study
that they are resistant to digestion by keratanase enzyme, but
are removed by chondroitinase ABC and thus most likely carry
CS/DS-GAG chains. It remains to be determined whether in-
creased sulfation of CS/DS PGs compensates for the undersul-
fation of KS PG in the mouse cornea. A maximum length of 600
nm was recorded for these structures, although the possibility
cannot be excluded that these are merely portions, viewed in
two dimensions, of longer structures running a continuous, but
tortuous, course throughout the tissue. Although their elec-
tron-dense core component showed no regular association
with stromal collagen fibrils, occasionally threadlike lateral
extensions were present that appeared to make contact with
the fibrils. They may therefore have a role in maintaining
lamellar integrity.
In conclusion, there appear to be distinctive differences
between mouse corneal PGs and those described in other
animal species. The KS-GAGs on KS PGs seem to contain more
N-acetyl lactosamine disaccharides that are nonsulfated with
no extended (pentasaccharide) domains containing disulfated
disaccharide. Alternatively, the KS-GAGs are of shorter chain
length than a pentasaccharide. Both of these possibilities
would explain the absence of 5D4 antibody reactivity in mouse
cornea. In addition, large chondroitinase ABC-sensitive PGs are
present that, from their cationic dye staining structure, appear
to have numerous CS/DS chains. We suggest that these unusual
aspects of the mouse cornea be taken into account in the
interpretation of data derived from studies of corneas in trans-
genic mouse strains.
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